Where are we now and where do we go next in terms of the scientific basis for regulation on bioavailability and bioequivalence? FDA Biopharmaceutics Coordinating Committee
Eur J Drug Metab Pharmacokinet. 2000 Jan-Mar;25(1):7-12.
doi: 10.1007/BF03190049.